
==== Front
BMJ OpenBMJ OpenbmjopenbmjopenBMJ Open2044-6055BMJ Open BMA House, Tavistock Square, London, WC1H 9JR bmjopen-2016-012818corr110.1136/bmjopen-2016-012818corr1Miscellaneous1506Correction: Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study 2017 18 9 2017 7 9 e012818corr1© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.2017This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/special-featureunlocked
==== Body
Schmidt M, Mansfield KE, Bhaskaran K, et al. Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study. BMJ Open 2017;7:e012818. doi: 10.1136/bmjopen-2016-012818

In the 3rd column of Table 5 the heading ‘Serum potassium increase ≥30%*’ should read ‘Serum potassium increase >6 mmol/L’.

